These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15609893)

  • 1. Artificial neural networks for anticoagulant management--think again!
    Ellis MH
    Isr Med Assoc J; 2004 Dec; 6(12):770-1. PubMed ID: 15609893
    [No Abstract]   [Full Text] [Related]  

  • 2. Applying an artificial neural network to warfarin maintenance dose prediction.
    Solomon I; Maharshak N; Chechik G; Leibovici L; Lubetsky A; Halkin H; Ezra D; Ash N
    Isr Med Assoc J; 2004 Dec; 6(12):732-5. PubMed ID: 15609884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy.
    Ageno W; Johnson J; Nowacki B; Turpie AG
    Thromb Haemost; 2000 Jun; 83(6):849-52. PubMed ID: 10896237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulant therapy with warfarin--still difficult].
    Sandset PM
    Tidsskr Nor Laegeforen; 2002 Apr; 122(10):992. PubMed ID: 12082707
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice.
    Onundarson PT; Einarsdottir KA; Gudmundsdottir BR
    Int J Lab Hematol; 2008 Oct; 30(5):382-9. PubMed ID: 19046313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a MUMPS-based anticoagulant management system.
    Hunt B
    Br J Biomed Sci; 1993 Jun; 50(2):117-24. PubMed ID: 8219917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage.
    Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Jespersen J
    Br J Haematol; 2008 Oct; 143(2):274-83. PubMed ID: 18759767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer control of anticoagulant dose.
    BMJ; 1989 Dec; 299(6714):1529. PubMed ID: 2514885
    [No Abstract]   [Full Text] [Related]  

  • 10. Warfarin sensitivity and genetic polymorphisms: should pharmacokinetic screening be part of anticoagulant dosing decisions?
    Baglin TP
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):656-7. PubMed ID: 16258463
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics of warfarin response.
    Schillinger D
    N Engl J Med; 2008 Jun; 358(25):2741-2; author reply 2743-4. PubMed ID: 18565872
    [No Abstract]   [Full Text] [Related]  

  • 12. Perioperative management of oral anticoagulation.
    O'Donnell M; Kearon C
    Cardiol Clin; 2008 May; 26(2):299-309, viii. PubMed ID: 18407002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 15. Is computer-assisted, long-term warfarin therapy safe and efficacious for patients with nonrheumatic atrial fibrillation?
    Perez-Gomez F
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):82-3. PubMed ID: 16265377
    [No Abstract]   [Full Text] [Related]  

  • 16. Warfarin pharmacogenetics.
    Garcia DA; Hylek E
    N Engl J Med; 2009 Jun; 360(23):2474; author reply 2475. PubMed ID: 19494226
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 18. An audit of INR control in the Australian indigenous setting.
    Pickering A; Thomas DP
    Aust Fam Physician; 2007 Nov; 36(11):959-60, 967. PubMed ID: 18043786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: anticoagulation management in hip fracture patients on warfarin.
    Verma R
    Injury; 2007 Feb; 38(2):253. PubMed ID: 17052718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.